The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
News the HIV world has been waiting for – long-acting injectable cabotegravir (CAB-LA) is a potentially game-changing tool to prevent HIV in women.
The 23rd International AIDS Conference (AIDS 2020 Virtual) kicked-off with a clear message from UNAIDS to accelerate efforts to end AIDS and not be derailed by COVID-19.
The latest Lesotho national HIV survey reports high HIV prevalence among adults, but access to effective antiretroviral treatment is rapidly accelerating.
On International Safe Abortion Day (28 September), we give an overview of the link between HIV and abortion and the need for broader sexual reproductive health rights for women.
Scientists are hesitant to declare that there is no risk of HIV transmission during breastfeeding by mothers with an undetectable viral load, as they have done for sexual transmission. We talk through why it’s contentious.
In their first treatment update since 2016, the World Health Organization (WHO) adopts a ‘treat all’ approach for hepatitis C, guided by the success of the HIV treatment experience.
Dolutegravir’s first bump in the road to global roll-out begs larger questions around women’s rights and access to contraceptives at the International AIDS Conference (AIDS 2018).
Interim clinical trial results offer hope to people living with hepatitis C who stand to benefit from reduced price treatment, including the 2.3 million people who have HIV co-infection.
HIV self-testing leads to positive sexual behaviour change among Zambian female sex workers, according to new study.
Results from Latin America’s first PrEP demonstration project reveal that it is both feasible and effective as an HIV prevention method in the region. Will Brazil’s example pave the way for the rest of the region?